Single-dose tocilizumab blunts systemic inflammation in severe COVID-19 patients
Keywords
COVID-19
Immunotherapy
Tocilizumab
IL-6
Cited by (0)
- 1
Full list of investigators is available at the end of the article, [email protected]
© 2021 Elsevier Inc. All rights reserved.